Navigation Links
Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement
Date:7/7/2008

Large California Healthcare System to Address Key Issues of Security, Risk

& Cost

DALLAS, July 7 /PRNewswire-FirstCall/ -- Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI), the leader in hosted services for email encryption and e-prescribing, today announced an upcoming webcast featuring Daughters of Charity Health System on Thursday, July 10 at 4:00 p.m. ET. The webcast will feature Michael Day, Director of Information Technology, and Ajay Chaudhari, Network Design Specialist for Daughters of Charity and they will discuss their process for choosing and implementing a solution: how they built internal buy-in, identified and addressed potential pitfalls, and made critical decisions on replacing their previously implemented system with ZixCorp's Email Encryption Service.

To register for this informative webinar, please visit http://www.zixcorp.com/info/health or call 866-257-4949.

Additionally, the ZixCorp website is now featuring a Daughters of Charity success story that outlines issues that will be discussed during the upcoming webinar. Below is an excerpt from the success story:

"The security of protected health information (PHI) is very important," said Michael Day, Director of Information Technology for DCHS. "Not only from a regulatory standpoint enforced by the Health Insurance Portability and Accountability Act (HIPAA), but because our patients and staff need to have that confidence in us."

Not satisfied with the email encryption solution they were using, DCHS switched to ZixCorp's Email Encryption Service.

"With our old solution, we were concerned we were at risk of not properly protecting our patients' sensitive data or other important business information," said Day. "It was also a massive challenge to administer the whole process from installation through to mailbox management, information tracking and overall maintenance. We needed a more efficient and thorough process."

Day liked what ZixCorp had to offer because of its ease of use and excellent reputation as the leading email encryption solution for health care organizations. "It was simple to set up, fast to deploy, and transparent to use," he said. "It has a better hit rate of encrypting messages than our previous solution. ZixCorp's service detects PHI and other sensitive information and ensures they're secured before delivery."

To read the entire DCHS success story, please visit the ZixCorp website or click on the following link: http://www.zixcorp.com/pdf/ZIX-DCHS_CaseStudy_Web.pdf.

About Zix Corporation

ZixCorp is the leading provider of easy-to-use-and-deploy email encryption and e-prescribing services that Connect entities with their customers and partners to Protect and Deliver sensitive information in the healthcare, finance, insurance and government industries. ZixCorp's hosted Email Encryption Service provides an easy and cost-effective way to ensure customer privacy and regulatory compliance for corporate email. Its PocketScript(R) e-prescribing service saves lives and saves money by automating the prescription process between payors, doctors and pharmacies. For more information, visit http://www.zixcorp.com.


'/>"/>
SOURCE Zix Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 2017 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that Mr. Michael Merges, Director of Strategic Growth, Catalent Biologics ... at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, 2017. , ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... the first time support an aid project with the donation of cochlear implants. ... the gift of hearing and thus a fair chance of leading an independent ...
(Date:1/18/2017)... CA (PRWEB) , ... January 18, 2017 , ... ... dental problems ranging from gum disease to enamel erosion, and those dental problems ... Massachusetts Department of Public Health, many pregnant women are failing to get the ...
(Date:1/17/2017)... ... January 17, 2017 , ... January is National Stalking Awareness Month (NSAM), ... lurk in the corners and commit the crime of stalking, a very real danger to ... an often overlooked factor in stalking and other crimes. , “Stalking: know it. Name it. ...
(Date:1/17/2017)... ... 2017 , ... Gym Source, America’s leading retailer of premium residential and commercial ... in Miami, FL. , “We are elated to be opening this new showroom,” explains ... designed to give clients a seamless and motivating shopping experience.” , Every fitness journey ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... January 17, 2017 Management to Discuss ... Ltd.   KIT-302 Development On Track For An ... in Q1 2017   ... Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), an ... Monday, January 23 rd at 8:30am Eastern Time to discuss the recent ...
(Date:1/17/2017)... , Jan. 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... patient has been enrolled in a Phase 3 clinical ... best supportive care (BSC) in the prevention of hepatic ... hematopoietic stem cell transplant (HSCT) who are at high ... The defibrotide clinical trial will be conducted across approximately ...
(Date:1/17/2017)... 2017  Edwards Lifesciences Corporation (NYSE: EW ... heart disease and critical care monitoring, plans to announce ... 2016 after the market closes on Wednesday, February 1, ... p.m. ET that day to discuss those results. ... 407-8037 or (201) 689-8037.  For 72 hours following the ...
Breaking Medicine Technology: